Virpax Pharmaceuticals files to sell common stock and warrants, no amount given
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2025
0mins
Source: Business Insider
Virpax Pharmaceuticals Stock Offering: Virpax Pharmaceuticals (VRPX) has filed to sell common stock and warrants, although the specific amount has not been disclosed.
Recent Company Developments: The company has reported various updates including human study data on Molecular Envelope Technology, confirmed results with the U.S. Army regarding Probudur, appointed a new independent director, and experienced a board member resignation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
